Lam Research (LRCX) Boasts Earnings & Price Momentum: Should You Buy?
Werte in diesem Artikel
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.One of our most popular services, Zacks Premium offers daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter. All are useful tools to find what stocks to buy, what to sell, and what are today's hottest industries.Also included in Zacks Premium is the Focus List. This is a long-term portfolio of top stocks that have all the traits to beat the market.Breaking Down the Zacks Focus ListIf you could, wouldn't you jump at the chance for access to a curated list of stocks to kickstart your investing journey?That's what the Zacks Focus List, a portfolio of 50 stocks, offers investors. Not only does it serve as a starting point for long-term investors, but all stocks included in the list are poised to outperform the market over the next 12 months.Additionally, each selection is accompanied by a full Zacks Analyst Report, something that makes the Focus List even more valuable. The report explains in detail why each stock was picked and why we believe it's good for the long-term.The portfolio's past performance only solidifies why investors should consider it as a starting point. For 2020, the Focus List gained 13.85% on an annualized basis compared to the S&P 500's return of 9.38%. Cumulatively, the portfolio has returned 2,519.23% while the S&P returned 854.95%. Returns are for the period of February 1, 1996 to March 31, 2021.Focus List MethodologyWhen stocks are picked for the Focus List, it reflects our enduring reliance on the power of earnings estimate revisions.Earnings estimates are expectations of growth and profitability, and are determined by brokerage analysts. Together with company management, these analysts examine every aspect that may affect future earnings, like interest rates, the economy, and sector and industry optimism.Investors also need to look at what a company will earn down the road. This is why earnings estimate revisions are so important.When a stock receives upward earnings estimate revisions, it will likely get even more positive changes in the future. For instance, if an analyst raised their earnings outlook last month, they'll probably do so again this month, and other analysts will follow.Harnessing the power of earnings estimate revisions is where the Zacks Rank comes in. The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions to make it easier to build a winning portfolio.Four primary factors make up the Zacks Rank: Agreement, Magnitude, Upside, and Surprise. Each is given a raw score that's recalculated every night and compiled into the Rank, and with this data, stocks are then classified into five groups, ranging from "Strong Buy" to "Strong Sell."The Focus List is comprised of stocks hand-picked from a long list of #1 (Strong Buy) or #2 (Buy) ranked companies, meaning that each new addition boasts a bullish earnings consensus among analysts.Because stock prices react to revisions, buying stocks with rising earnings estimates can be very profitable. Focus List stocks offer investors a great opportunity to get into companies whose future earnings estimates will be raised, potentially leading to price momentum.Focus List Spotlight: Lam Research (LRCX)Headquartered in Fremont, CA, Lam Research Corporation supplies wafer fabrication equipment and services to the semiconductor industry. In addition, it serves the related markets that rely on semiconductor processes and require production-proven manufacturing capabilities, such as complementary metal-oxide-semiconductor image sensors and micro-electromechanical systems (MEMS).Since being added to the Focus List on December 5, 2016 at $10.05 per share, shares of LRCX have increased 772.24% to $87.66. The stock is currently a #3 (Hold) on the Zacks Rank.Nine analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, while the Zacks Consensus Estimate has increased $0.20 to $3.71. LRCX also boasts an average earnings surprise of 6.9%.Earnings for LRCX are forecasted to see growth of 24.1% for the current fiscal year as well.Reveal Winning StocksUnlock all of our powerful research, tools and analysis, including the Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. You'll quickly identify which stocks to buy, hold and sell, and target today's hottest industries, to help improve the performance of your portfolio. Gain full access now >>5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lam Research Corporation (LRCX): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Lam Research
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Lam Research
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Lam Research Corp.
Analysen zu Lam Research Corp.
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2019 | Lam Research Outperform | Cowen and Company, LLC | |
22.04.2019 | Lam Research Buy | B. Riley FBR | |
24.01.2019 | Lam Research Outperform | Cowen and Company, LLC | |
21.12.2018 | Lam Research Buy | Needham & Company, LLC | |
29.10.2018 | Lam Research Neutral | B. Riley FBR |
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2019 | Lam Research Outperform | Cowen and Company, LLC | |
22.04.2019 | Lam Research Buy | B. Riley FBR | |
24.01.2019 | Lam Research Outperform | Cowen and Company, LLC | |
21.12.2018 | Lam Research Buy | Needham & Company, LLC | |
17.10.2018 | Lam Research Outperform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
29.10.2018 | Lam Research Neutral | B. Riley FBR | |
01.10.2018 | Lam Research Hold | Deutsche Bank AG | |
01.10.2018 | Lam Research Neutral | Mizuho | |
12.10.2016 | Lam Research Sector Weight | Pacific Crest Securities Inc. | |
21.04.2015 | Lam Research Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
22.10.2015 | Lam Research Underperform | RBC Capital Markets | |
05.10.2015 | Lam Research Underperform | RBC Capital Markets | |
11.11.2010 | Lam Research sell | Citigroup Corp. | |
29.07.2010 | Lam Research sell | Citigroup Corp. | |
19.03.2009 | Lam Research underperform | Credit Suisse Group |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen